Boston Scientific Corporation (BSX) : On Tuesday, The money flowed into the Boston Scientific Corporation (BSX) stock with an uptick to downtick ratio was recorded at 1.17. Transactions worth $45.92 million were done on upticks, confirming the buying interest in the stock. The outflow of money on downticks stood at $39.21 million. The total money flow into the stock was $6.71 million. The block trades reveal a bullish bias with an up-down ratio of 1.48. The investors are using every small weakness in the stock to accumulate it, as can be seen in the $22.39 million of block transactions on upticks. The value of block trades on downticks was $15.12 million, indicating lower selling interest. The total money flow in block trades was $7.27 million. In terms of price action, Boston Scientific Corporation (BSX) traded down $0.13 during the session at $23.64. Compared to the previous days closing, the stock was down only by -0.55%. For the week, the stock is -1.09%, over previous weeks closing.
The company Insiders own 1.31% of Boston Scientific Corporation shares according to the proxy statements. In the past twelve weeks, the net percent change held by company insiders has changed by -21.25% . Institutional Investors own 93.3% of Boston Scientific Corporation shares. During last six month period, the net percent change held by insiders has seen a change of -25.56%. In an insider trading activity,The officer (EVP, GC & Chief Admin Officer) of Boston Scientific Corp, Pratt Timothy A. sold 24,000 shares at $23.39 on July 1, 2016. The Insider selling transaction had a total value worth of $561,360. The Insider information was disclosed with the Securities and Exchange Commission in a Form 4 filing.
Shares of Boston Scientific Corporation rose by 1.46% in the last five trading days and 2.69% for the last 4 weeks. Boston Scientific Corporation is up 22.42% in the last 3-month period. Year-to-Date the stock performance stands at 28.2%.
Boston Scientific Corporation (NYSE:BSX): On Tuesdays trading session , Opening price of the stock was $23.83 with an intraday high of $23.99. The bears continued to sell at higher levels and eventually sold the stock down to an intraday low of $23.58. However, the stock managed to close at $23.64, a loss of 0.55% for the day. On the previous day, the stock had closed at $23.77. The total traded volume of the day was 11,958,919 shares.
Boston Scientific Corporation develops, manufactures and markets medical devices. The Company offers its products by seven core businesses: Interventional Cardiology, which includes Drug-Eluting Coronary Stent Systems, Intravascular Imaging devised and Coronary Technology products, such as guide wires, guide catheters, and balloon catheters, among others; Peripheral Interventions (PI), which include stents, balloon catheters, wires, peripheral embolization devices and vena cava filters; Cardiac Rhythm Management (CRM), which include implantable devices that monitor the heart and deliver electricity to treat cardiac abnormalities; Electrophysiology (EP), which include steerable RF ablation catheters, intracardiac ultrasound catheters, diagnostic catheters, delivery sheaths, and other accessories; Endoscopy, which includes Spyglass System, WallFlex Colonic Stents, Resolution Clip, and Expect Aspiration Needle, among others; Urology and Womens Health, and Neuromodulation.